Azelaic acid 15% gel: In the treatment of papulopustular rosacea

American Journal of Clinical Dermatology

Volumn 5, Issue 1, 2004, Pages 57-64

  Frampton, James E ^a   Wagstaff, Antona J ^a  

^a ADIS INTERNATIONAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; FINACEA; METRONIDAZOLE;

ACNE; ANTIINFLAMMATORY ACTIVITY; BURNING SENSATION; CLINICAL TRIAL; CONTACT DERMATITIS; DEPIGMENTATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG APPROVAL; DRUG DOSE; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; FACE EDEMA; HEADACHE; HERPES LABIALIS; HUMAN; HYPERTRICHOSIS; KERATOSIS; PAIN; PAPULAR SKIN DISEASE; PHOTOALLERGY; PHOTOTOXICITY; PRIORITY JOURNAL; PRURITUS; PUSTULE; REVIEW; ROSACEA; SEBORRHEA; SIDE EFFECT; SKIN IRRITATION; STEADY STATE; TREATMENT INDICATION; VITILIGO; XEROSIS;

ADMINISTRATION, CUTANEOUS; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; GELS; HUMANS; RANDOMIZED CONTROLLED TRIALS; ROSACEA; SEVERITY OF ILLNESS INDEX;

EID: 1542343877     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200405010-00009     Document Type: Review

References (31)

1. Blount BW, Pelletier AL. Rosacea: a common, yet commonly overlooked, condition. Am Fam Physician 2002 Aug 1; 66 (3): 435-40
2. Millikan L. Recognizing rosacea. Could you be miiagnosing this common skin disorder? Postgrad Med 1999 Feb; 105 (2): 149-58
3. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002 Apr; 46 (4): 584-7
4. Jansen T, Plewig G. Rosacea: classification and treatment. J R Soc Med 1997 Mar; 90: 144-50
5. Barankin B, Guenther L. Rosacea and atopic dermatitis. Two common oculocutaneous disorders. Can Fam Physician 2002 Apr; 48: 721-4
6. Cohen AF, Tiemstra JD. Diagnosis and treatment of rosacea. J Am Board Fam Pract 2002 May; 15 (3): 214-7
7. Rebora A. The management of rosacea. Am J Clin Dermatol 2002; 3 (7): 489-96
8. Del Rosso JQ. A status report on the medical management of rosacea: focus on topical therapies. Cutis 2002 Nov; 70 (5): 271-5
9. Topical metronidazole: well tolerated alternative to oral antibacterials for rosacea. Drug Ther Perspect 2000 Nov 20; 16 (11): 1-4
10. Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 2003; 4 (7): 473-92
11. Breathnach AS. Pharmacological properties of azelaic acid: a rationale for clinical use. Clin Drug Invest 1995; 10 Suppl. 2: 27-33
12. Breathnach AS. Azelaic acid: biological activities and therapeutic applications. Drugs Today 1989; 25 (7): 463-72
13. Kakita LS. Azelaic acid in the treatment of acne, rosacea, and hyperpigmentary skin diseases. Today's Therapeutic Trends 1997; 14 (4): 251-66
14. Fitton A, Goa KL. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 1991 May; 41 (5): 780-98
15. Carmichael A, Marks R, Graupe KA, et al. Topical azelaic acid in the treatment of rosacea. J Dermatol Treat 1993; 4 Suppl. 1: S19-22
16. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 1999 Jun; 40 (6 Pt 1): 961-5
17. Bjerke R, Fyrand O, Graupe K. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea. Acta Derm Venereol 1999 Nov; 79 (6): 456-9
18. Draelos ZC, Graupe K. A new topical formulation for the treatment of moderate, papulopustular rosacea: azelaic acid 15% gel [abstract no. P49 plus poster]. 61st Annual Meeting of the American Academy of Dermatology; 2003 Mar 21-26; San Francisco, 20
19. Mayer-da-Silva A. Azelaic acid: pharmacology, toxicology and mechanism of action in acne. J Dermatol Treat 1989; 1 Suppl. 1: 11-5
20. Topert M, Rach P, Siegmund F. Pharmacology and toxicology of azelaic acid. Acta Derm Venereol Suppl (Stockh) 1989; 143: 14-9
21. Passi S, Picardo M, Zompetta C, et al. The oxyradical-scavenging activity of azelaic acid in biological systems. Free Radic Res Commun 1991; 15(1): 17-28
22. Passi S, Picardo M, De Luca C, et al. Scavenging activity of azelaic acid on hydroxyl radicals "in vitro". Free Radic Res Commun 1991; 11 (6): 329-38
23. Akamatsu H, Komura J, Asada Y. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res 1991; 283 (3): 162-6
24. Berlex Laboratories. Finacea™ (azelaic acid) gel 15%: US prescribing information. Montville, NJ, USA. 2003
25. Tauber U, Weiss C, Matthes H. Percutaneous absorption of azelaic acid in humans. Exp Dermatol 1992 Nov; 1 (4): 176-9
26. Passi S, Picardo M, Mingrone G, et al. Azelaic acid-biochemistry and metabolism. Acta Derm Venereol Suppl (Stockh) 1989; 143: 8-13
27. Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomised, phase III studies. J Am Acad Dermatol 2003 Jun; 48 (6): 836-45
28. Elewski B. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea. Arch Dermatol 2003; 139: 1444-50
29. Thiboutot D, Thieroff-Ekerdt R. A new static score to assess papulopustular (Slage 2) rosacea: experience from 2 large, vehicle-controlled phase 3 studies comparing a new azelaic acid 15% gel formulation to its vehicle [abstract no. P81 plus poster]. 61st Annual Meeting of the American Academy of Dermatology; 2003 Mar 21-26; San Francisco, 33
30. Hebert AA. Azelaic acid 15% gel reduces the intensity of erythema in patients with moderate, papulopustular facial rosacea: data from two phase 3 trials [abstract no. P55 plus poster]. 61st Annual Meeting of the American Academy of Dermatology; 2003 Mar 21-26; San Francisco, 23
31. Berlex Laboratories. FDA Approves FINACEA™ for the topical treatment of rosacea. [media release] 2003 Jan 2